1. VX950 : 52% des patients indetectables
(Recherche Medicale/Les anti-protéases)

...gInterferon et Ribavirine) Depuis le milieu de semaine dernière, JP Morgan, Oppenheimer, Citi Investment Research, etc... classent Vertex pharm. comme "outperform", ce qui veut dire, acheter achet...

2. Vaccin en test contre l'hepatite C
(Recherche Medicale/Traitement)

Researchers at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) have developed a vaccine candidate for hepatitis C, leading to hope in the fight against a disease